In early 2020, due to reagent and labware shortages, there were significant limitations on SARS-CoV-2 testing capacity worldwide, with the UK’s diagnostic capacity at only 10 000 tests per day at the beginning of April. The London Biofoundry worked together with NHS colleagues to successfully increase testing capacity in accredited NHS laboratories at the St
Develop Intensify Explore Enhance
The overall objective of GBA is to:
1. Develop, promote, and support non-commercial biofoundries established around the world,
2. Intensify collaboration and communication among biofoundries,
3. Collectively develop responses to technological, operational, and other types of common challenges,
4. Enhance visibility, impact and sustainability of non-commercial biofoundries, and
5. Explore globally relevant and societally impactful grand challenge collaborative projects.
